Hjem › Glykogengemmelsessygdom type II › Missouri
Glykogengemmelsessygdom type II kliniske forsøg i Missouri
6 studier for Glykogengemmelsessygdom type II søger deltagere på steder i Missouri.
Byer i Missouri
Officiel studietekst (engelsk)
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
- Washington University School of Medicine, St Louis
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT07354724Pompe Disease Registry Protocol
- University of Missouri Health System Department of Genetics- Site Number : 840031, Columbia
- Washington University- Site Number : 840100, St Louis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 23. jun. 2026 · NCT00231400Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
- Washington University in St. Louis, St Louis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT07123155Pompe Pregnancy Sub-Registry
- Washington University- Site Number : 150612, St Louis
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 16. apr. 2026 · NCT00567073Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT07478172A Global Prospective Observational Registry of Patients With Pompe Disease
- Washington University School of Medicine, St Louis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 10. mar. 2026 · NCT06121011Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.